SK

Shinesh Kuzhiyengal

Active Director Director DIN 10101855
DIN 10101855 First appointment Apr 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Shinesh Kuzhiyengal

Data last updated:

Shinesh Kuzhiyengal is a Director at Izil Life Sciences Private Limited (since 2023). Izil Life Sciences Private Limited reported revenue of ₹7.9 Lakh (FY 2025).

DIN 10101855
Primary Designation Director
First Appointment 05 Apr 2023
Oldest Company Age 3 yrs
Largest company Izil Life Sciences Private Limited · ₹7.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Izil Life Sciences Private Limited U46497KA2023PTC171892
Director05 Apr 20232023₹7.9 Lakh (FY 2025)Active

Board colleagues of Shinesh Kuzhiyengal

NameDINCompanyDesignation
Reshma10101856Izil Life Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Izil Life Sciences Private Limited
Premium access

Shareholding and investment profile for Shinesh Kuzhiyengal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shinesh Kuzhiyengal

Shinesh Kuzhiyengal currently holds 1 directorship: Izil Life Sciences Private Limited (Director, since 05 Apr 2023, revenue ₹7.9 Lakh (FY 2025)).

Shinesh Kuzhiyengal was first appointed on 05 Apr 2023 as Director at Izil Life Sciences Private Limited.

The current boards of Shinesh Kuzhiyengal's companies include Reshma (Izil Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available